AI drug discovery biotech Recursion Pharmaceuticals files for a $100 million IPO - (NASDAQ via NewsPoints Desk)

  • Recursion Pharmaceuticals filed with the US Securities and Exchange Commission to raise up to $100 million in an initial public offering, as reported in NASDAQ.

  • The company is using machine learning to develop therapies for various indications.

  • While Recursion is advancing 37 programs, its most advanced programs include one candidate targeting oncology and three targeting rare genetic disorders, all of which are set to enter Phase II or II/III trials within the next four to five quarters.

To read more NewsPoints articles, click here.